Close Comment Creative Commons Donate Email Add Email Facebook Instagram Facebook Messenger Mobile Podcast Print RSS Search Secure Twitter WhatsApp YouTube
Close this

David Armstrong

Senior Reporter

David Armstrong is a senior reporter at ProPublica, specializing in health care investigations. He joined ProPublica in March, 2018. Before that, he was a senior enterprise reporter for STAT, where he wrote about abuses in the addiction treatment industry, the rise of fentanyl and the recruiting of college football players with histories of concussions. Armstrong previously worked in the investigative unit at Bloomberg News, where he reported on the overuse of cardiac stents, problematic back surgeries and excesses in the pain industry.

Armstrong was also a reporter for nine years at the Wall Street Journal, where he reported on the influence of pharmaceutical and medical device companies on the practice of medicine – and the resulting harm to patients. He was part of the Journal staff awarded the 2002 Pulitzer Prize for breaking news reporting for coverage of the attacks of Sept. 11. Armstrong was a reporter for the Boston Globe from 1993 to 2000, where his investigation of safety flaws in elevators and escalators won a George Polk Award and the Investigative Reporters and Editors award.

Doctors Defending Convicted Child Abuser “Exceed the Limits of Credulity,” Judge Rules

The decision in a closely watched Florida case was a setback for Dr. David Ayoub, following our recent article about his work as an expert witness.

An Anti-Vaxxer’s New Crusade

Dr. David Ayoub used to be active in the anti-vaccination movement. Now he’s challenging mainstream science again — as an expert witness for accused child abusers.

The Child Abuse Contrarian

Michael Holick, a renowned scientist turned expert witness, relies on his own controversial theory to help alleged abusers avoid prison and regain custody of the babies they were accused of harming.

Sacklers Who Disavow OxyContin May Have Benefited From It

A little-known court document sheds light on the family feud over the multibillion-dollar painkiller’s association with the opioid crisis.

Follow ProPublica

Latest Stories from ProPublica

Current site Current page